2023論文
1 | Agreement regarding overcoming hypertension in the Asian Hypertension Society Network 2022. Hoshide S, Yamamoto K, Katsurada K, Yano Y, Nishiyama A, Wang J, Narasingan S N, Verma N, Erwinanto E, Turana Y, Ihm S, Park S, Nik Sherina H, Chia Y, Unurjargal T, Siddique S, D Ona I, enketasubramanian N, Teo B W, Constantine G, Kao H, Hung C, Sukonthasarn A, Kunanon S, Van Minh H, Kario K, Node K, Itoh H, Rakugi H. Hypertens Res. 2023 Jan;46(1):3-8. doi: 10.1038/s41440-022-00994-1. Epub 2022 Oct 14. |
2 | Simultaneous SGLT2 inhibition and caloric restriction improves insulin resistance and kidney function in OLETF rats. Cornejo MA, Jardines E, Nishiyama A, Nakano D, Ortiz R M. Mol Cell Endocrinol. 2023 Jan 15;560:111811. doi: 10.1016/j.mce.2022.111811. Epub 2022 Oct 29. |
3 | (Pro)renin receptor promotes colorectal cancer progression through inhibiting the NEDD4L-mediated Wnt3 ubiquitination
and modulating gut microbiota. Wang J, Ding Y, Li D, Zhu N, Nishiyama A, Yuan Y. Cell Commun Signal. 2023 Jan 3;21(1):2. doi: 10.1186/s12964-022-01015-x. Epub 2022 Oct 14. |
4 | Contributions of renal water loss and skin water conservation to blood pressure elevation in spontaneously hypertensive rats. Ogura T, Kitada K, Morisawa N, Fujisawa Y, Kidoguchi S, Nakano D, Kobara H, Masaki T, Titze J, Nishiyama A. Hypertens Res. 2023 Jan;46(1):32-39. doi: 10.1038/s41440-022-01044-6. Epub 2022 Oct 14. |
5 | Vasoactive intestinal peptide blockade suppresses tumor growth by regulating macrophage polarization and function
in CT26 tumor-bearing mice. Kittikulsuth W, Nakano D, Kitada K, Uyama T, Ueda N, Asano E, Okano K, Matsuda Y, Nishiyama A. Sci Rep. 2023 Jan 17;13(1):927. doi: 10.1038/s41598-023-28073-6. |
6 | Blood pressure control with renin-angiotensin system inhibitors in hypertension patients with cancer - good or bad? Kidoguchi S, Nishiyama A. Hypertens Res. 2023 Feb;46(2):529-531. doi: 10.1038/s41440-022-01110-z. Epub 2022 Nov 29. |
7 | Mapping the protein binding site of the (pro)renin receptor using in silico 3D structural analysis. Ebihara A, Sugihara D, Matsuyama M, Suzuki-Nakagawa C, Nurun Nabi A H M, Nakagawa T, Nishiyama A, Suzuki F. Hypertens Res. 2023 Apr;46(4):959-971. doi: 10.1038/s41440-022-01094-w. Epub 2022 Dec 9. |
8 | Economic evaluation of a new blood pressure target for hypertensive patients in Taiwan. Minegishi S, Nishiyama A. Hypertens Res. 2023 Mar;46(3):784-786. doi: 10.1038/s41440-022-01125-6. Epub 2023 Jan 5. |
9 | Angiotensin receptor blockade with olmesartan alleviates brain pathology in obese OLETF rats. Rodriguez-Ortiz C J, Thorwald M A, Rodriguez R, Mejias-Ortega M, Kieu Z, Maitra N, Hawkins C, Valenzuela J, Peng M, Nishiyama A, Ortiz R M, Kitazawa M. Clin Exp Pharmacol Physiol. 2023 Mar;50(3):228-237. doi: 10.1111/1440-1681.13738. Epub 2022 Dec 4. |
10 | The Renin-Angiotensin-Aldosterone System in Metabolic Diseases and Other Pathologies Rudy M Ortiz , Ryousuke Satou , Jia L Zhuo , Akira Nishiyama Int J Mol Sci. 2023 Apr 18;24(8):7413. doi: 10.3390/ijms24087413. |
11 | Possible contribution of phosphate to the pathogenesis of chronic kidney disease in dolphins Nourin Jahan , Hiroyuki Ohsaki , Kiyoko Kaneko , Asadur Rahman , Takeshi Nishiyama , Makoto Koizumi , Shuichiro Yamanaka , Kento Kitada , Yuki Sugiura , Kenji Matsui , Takashi Yokoo , Takayuki Hamano , Makoto Kuro-O , Takuya Itou , Miwa Suzuki , Keiichi Ueda , Akira Nishiyama Sci Rep. 2023 Mar 29;13(1):5161. doi: 10.1038/s41598-023-32399-6. |
12 | Comparison of endoscopic closure versus non-closure for post-gastric endoscopic submucosal dissection artificial floor in antithrombotic therapy: a propensity score-matched analysis Nobuya Kobayashi , Hideki Kobara , Noriko Nishiyama , Joji Tani , Taiga Chiyo , Kazuhiro Kozuka , Naoya Tada , Takanori Matsui , Shintaro Fujihara , Tatsuo Yachida , Koji Fujita , Akihiro Kondo , Keiichi Okano , Akira Nishiyama , Tsutomu Masaki Ann Gastroenterol. 2023 Mar-Apr;36(2):178-184. doi: 10.20524/aog.2023.0771. Epub 2023 Jan 2. |
13 | Effects of a monoclonal antibody against (pro)renin receptor on gliomagenesis Takeshi Fujimori , Yuki Shibayama , Takahiro Kanda , Kenta Suzuki , Daisuke Ogawa , Ryou Ishikawa , Kyuichi Kadota , Toru Matsunaga , Takashi Tamiya , Akira Nishiyama , Keisuke Miyake Sci Rep. 2023 Jan 16;13(1):808. doi: 10.1038/s41598-023-28133-x. |
14 | Potential Impact of Non-Steroidal Mineralocorticoid Receptor Antagonists in Cardiovascular Disease Asadur Rahman, Nourin Jahan, Md Tanvir Rahman, Akira Nishiyama Int J Mol Sci. 2023 Jan 18;24(3):1922. doi: 10.3390/ijms24031922. |
15 | Possible renoprotective mechanisms of SGLT2 inhibitors Akira Nishiyama, Kento Kitada Front Med (Lausanne). 2023 Mar 9;10:1115413. doi: 10.3389/fmed.2023.1115413. eCollection 2023. |
16 | The VIPR2-selective antagonist KS-133 changes macrophage polarization and exerts potent anti-tumor effects as a single agent and in combination with an anti-PD-1 antibody Kotaro Sakamoto, Wararat Kittikulsuth, Eijiro Miyako, Akumwami Steeve, Rika Ishimura, Shinsaku Nakagawa , Yukio Ago, Akira Nishiyama PLoS One. 2023 Jul 5;18(7):e0286651. doi: 10.1371/journal.pone.0286651. eCollection 2023 |
17 | What impacts do the new ESH 2023 guidelines have on the management of hypertension in Japan? Kazuomi Kario, Satoshi Hoshide, Masaki Mogi, Akira Nishiyama, Yusuke Ohya, Koichi Node Hypertens Res. 2023 Oct;46(10):2257-2261. doi: 10.1038/s41440-023-01376-x. Epub 2023 Jul 21. |
18 | Association of cancer with the risk of developing hypertension Hajime Nagasawa, Hidehiro Kaneko, Yuta Suzuki, Akira Okada, Katsuhito Fujiu, Norifumi Takeda, Hiroyuki Morita, Akira Nishiyama, Yuichiro Yano, Koichi Node, Anthony J Viera, Robert M Carey, Suzanne Oparil, Hideo Yasunaga, Rhian M Touyz, Issei Komuro Eur Heart J Qual Care Clin Outcomes. 2023 Jun 15;qcad036. doi: 10.1093/ehjqcco/qcad036. Online ahead of print. |
19 | Future Prospects of Onco-Hypertension Shintaro Minegishi, Akira Nishiyama, Yuichiro Yano, Koichi Node; JSH Working Group Onco-Hypertension Hypertension. 2023 Jul;80(7):e123-e124. doi: 10.1161/HYPERTENSIONAHA.123.21011. Epub 2023 May 11. |
20 | Revisiting blood pressure and body fluid status Kento Kitada, Akira Nishiyama Clin Sci (Lond). 2023 May 18;137(9):755-767. doi: 10.1042/CS20220500. |
21 | Possible organ-protective effects of renal denervation: insights from basic studies Steeve Akumwami, Asahiro Morishita, Achille Iradukunda, Hideki Kobara, Akira Nishiyama Hypertens Res. 2023 Dec;46(12):2661-2669. doi: 10.1038/s41440-023-01393-w. Epub 2023 Aug 2. |
22 | Antiproliferative effects of D-allose associated with reduced cell division frequency in glioblastoma Kenta Suzuki, Daisuke Ogawa, Takahiro Kanda, Takeshi Fujimori, Yuki Shibayama, Asadur Rahman, Juanjuan Ye, Hiroyuki Ohsaki, Kazuya Akimitsu, Ken Izumori, Takashi Tamiya, Akira Nishiyama, Keisuke Miyake Sci Rep. 2023 Nov 9;13(1):19515. doi: 10.1038/s41598-023-46796-4. |
23 | (Pro)renin Receptor Down-regulation Is Associated With a Higher Risk of
Recurrence in Lung Adenocarcinoma Nachino Kimura, Kyuichi Kadota, Emi Ibuki, Ryou Ishikawa, Toshihiro Ikeda, Chihiro Yoshida, Toshiki Yajima, Akira Nishiyama, Reiji Haba Anticancer Res. 2023 Dec;43(12):5671-5680. doi: 10.21873/anticanres.16772. |
24 | Klotho Supplementation Reverses Renal Dysfunction and Interstitial Fibrosis
in Remnant Kidney Tsuneo Takenaka, Arif Hasan, Takeshi Marumo, Tsutomu Inoue, Takashi Miyazaki, Hiromichi Suzuki, Yoshifumi Kurosaki, Naohito Ishii, Akira Nishiyama, Matsuhiko Hayashi Kidney Blood Press Res. 2023;48(1):326-337. doi: 10.1159/000530469. Epub 2023 Apr 5. |